Literature DB >> 9695728

CYP3A4 and the erythromycin breath test.

D Wagner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9695728     DOI： 10.1016/S0009-9236(98)90031-5

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  9 in total

Review 1.  The erythromycin breath test for the prediction of drug clearance.

Authors:  L P Rivory; K A Slaviero; J M Hoskins; S J Clarke
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Pharmacokinetic Interaction between amprenavir and rifabutin or rifampin in healthy males.

Authors:  R E Polk; D F Brophy; D S Israel; R Patron; B M Sadler; G E Chittick; W T Symonds; Y Lou; D Kristoff; D S Stein
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of docetaxel : recent developments.

Authors:  Sharyn D Baker; Alex Sparreboom; Jaap Verweij
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Effect of ABCC2 (MRP2) transport function on erythromycin metabolism.

Authors:  R M Franke; C S Lancaster; C J Peer; A A Gibson; A M Kosloske; S J Orwick; R H Mathijssen; W D Figg; S D Baker; A Sparreboom
Journal:  Clin Pharmacol Ther       Date:  2011-03-30       Impact factor: 6.875

5.  Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers.

Authors:  Y Khaliq; K Gallicano; C Tisdale; G Carignan; C Cooper; A McCarthy
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

6.  Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers.

Authors:  D F Brophy; D S Israel; A Pastor; C Gillotin; G E Chittick; W T Symonds; Y Lou; B M Sadler; R E Polk
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

7.  Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients.

Authors:  Stéphane Mouly; Nathalie Rizzo-Padoin; Guy Simoneau; Céline Verstuyft; Guy Aymard; Cécile Salvat; Isabelle Mahé; Jean-François Bergmann
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

8.  Gefitinib-phenytoin interaction is not correlated with the C-erythromycin breath test in healthy male volunteers.

Authors:  Stephanie Chhun; Celine Verstuyft; Nathalie Rizzo-Padoin; Guy Simoneau; Laurent Becquemont; Ilana Peretti; Alan Swaisland; Robert Wortelboer; Jean Francois Bergmann; Stephane Mouly
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

9.  Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?

Authors:  Sompon Wanwimolruk; Mary F Paine; Susan N Pusek; Paul B Watkins
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.